Subscribe to RSS - Option Care

Option Care

In brief: Coloplast buys Comfort Medical for $160M, senators introduce bill to preserve access to diabetes supplies

 - 
12/02/2016

MINNEAPOLIS – Coloplast, which has its U.S. headquarters here but is based in Denmark, has entered into a definitive agreement to acquire Coral Springs, Fla.-based Comfort Medical for $160 million in cash, the company announced Nov. 30.

Home infusion providers make gains

 - 
12/02/2016

MedTrakRx, a pharmacy benefit manager, has selected ARJ Infusion Services, a specialty pharmacy, to provide home infusion therapies to patients with complex, rare and chronic conditions.

Short takes: Wilpage, Option Care

 - 
09/21/2016

Wilpage, a provider of home medical equipment in the New York metro area, has purchased Mediware’s CareTend software to boost its growing business.

Technology, need drive growth in enteral market

 - 
08/19/2016

The enteral nutrition market is having a growth spurt, thanks to a combination of factors that show no signs of slowing down.

In brief: Industry stays busy, Margolis passes away

 - 
07/29/2016

WASHINGTON – Although lawmakers are on recess, HME industry stakeholders have been holding strategy sessions on efforts to push through relief in non-bid areas.

Close monitoring of patients ensures outcomes, savings

 - 
07/26/2016

ORLANDO, Fla. ­–­ Close monitoring of hemophilia patients ensures bleed rate stays low and the patients can be managed with less factor VIII, according to a study by Option Care being presented at the World Federation of Hemophilia 2016 World Congress meeting today.

In brief: CQRC asks CMS to slow down, Circadiance readies rebrand

 - 
06/03/2016

WASHINGTON – The Council for Quality Respiratory Care says the findings of a recent Office of Inspector General report further demonstrate the need to slow down the national rollout of Medicare’s competitive bidding program.

Option Care awarded enteral contracts

 - 
06/03/2016

BANNOCKBURN, Ill. – Option Care has accepted contracts in the Round 2 re-compete to provide enteral nutrition services across the country. The provider has participated in the competitive bidding program since 2011.

Study: Patient monitoring limits adverse drug effects

 - 
03/22/2016

NEW ORLEANS – Close monitoring of patients receiving infusions of infliximab prevented adverse drug events, according to a new study from Option Care.

Outcomes prove value

 - 
01/22/2016

SAN ANTONIO – Although it may seem like a no-brainer that patients who receive infusion therapy at home fare better—and at less cost—than other patients, providers need hard data to make their case to payers, says Paul Mastrapa.

Pages